The contribution of alternative splicing to genetic risk for psychiatric disorders.

about

The contribution of alternative splicing to genetic risk for psychiatric disorders.

Item

http://www.wikidata.org/entity/Q47593150

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The contribution of alternative splicing to genetic risk for psychiatric disorders.

@en

The contribution of alternative splicing to genetic risk for psychiatric disorders.

@nl

type

Item

label

The contribution of alternative splicing to genetic risk for psychiatric disorders.

@en

The contribution of alternative splicing to genetic risk for psychiatric disorders.

@nl

prefLabel

The contribution of alternative splicing to genetic risk for psychiatric disorders.

@en

The contribution of alternative splicing to genetic risk for psychiatric disorders.

@nl

P1476

The contribution of alternative splicing to genetic risk for psychiatric disorders

@en

P2093

A Dineen

http://www.w3.org/2001/XMLSchema#string

E Reble

http://www.w3.org/2001/XMLSchema#string

P2860

An unappreciated role for RNA surveillance

Biological insights from 108 schizophrenia-associated genetic loci

Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia

Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes

Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis

Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes

Distinct protein forms are produced from alternatively spliced bicistronic glutamic acid decarboxylase mRNAs during development

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

Strong association of de novo copy number mutations with autism

A genome-wide association study of autism reveals a common novel risk locus at 5p14.1

P304

e12430

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/GBB.12430

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Cathy L. Barr

P577

2017-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29052934

http://www.w3.org/2001/XMLSchema#string